ABEONA THERAPEUTICS INC.
For the period ended Dec 31, 2025. Filed Mar 17, 2026.
View on SEC.govAbout this filing
A company's yearly report to the SEC, with audited financial statements. It is the fullest account a company gives of its business, its finances and the risks it sees.
FY2025 · Filed Mar 17, 2026
ABEO$2.46-3.3%Stored close · as of Nov 10, 2026
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
Consolidated Balance Sheets at December 31, 2025 and 2024
($ in thousands, except share and per share amounts)
| December 31, 2025 | December 31, 2024 | |
|---|---|---|
| ASSETS | ||
| Current assets: | ||
| Cash and cash equivalents | $78,437 | $23,357 |
| Short-term investments | 112,967 | 74,363 |
| Restricted cash | — | 338 |
| Accounts receivable, net | 6,147 | — |
| Inventory | 5,493 | — |
| Other receivables | 568 | 1,652 |
| Prepaid expenses and other current assets | 1,294 | 1,143 |
| Total current assets | 204,906 | 100,853 |
| Property and equipment, net | 9,921 | 4,430 |
| Operating lease right-of-use assets | 3,962 | 3,552 |
| Other assets | 781 | 96 |
| Total assets | $219,570 | $108,931 |
| LIABILITIES AND STOCKHOLDERS’ EQUITY | ||
| Current liabilities: | ||
| Accounts payable | $7,889 | $3,441 |
| Accrued expenses | 8,467 | 6,333 |
| Current portion of long-term debt | 12,222 | 5,926 |
| Current portion of operating lease liability | 864 | 823 |
| Accrued taxes | 126 | — |
| Other current liabilities | 2 | 64 |
| Total current liabilities | 29,570 | 16,587 |
| Long-term operating lease liabilities | 4,069 | 3,262 |
| Long-term debt | 7,813 | 13,037 |
| Warrant liabilities | 18,902 | 32,014 |
| Total liabilities | 60,354 | 64,900 |
| Commitments and contingencies | - | - |
| Stockholders’ equity: | ||
| Preferred stock - $0.01 par value; authorized 2,000,000 shares; No shares issued and outstanding as of December 31, 2025 and 2024, respectively | — | — |
| Common stock - $0.01 par value; authorized 200,000,000 shares; 55,043,413 and 45,644,091 shares issued and outstanding as of December 31, 2025 and 2024, respectively | 550 | 457 |
| Additional paid-in capital | 900,603 | 856,824 |
| Accumulated deficit | (742,075) | (813,258) |
| Accumulated other comprehensive loss | 138 | 8 |
| Total stockholders’ equity | 159,216 | 44,031 |
| Total liabilities and stockholders’ equity | $219,570 | $108,931 |
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.